PET FOCUS
Pet business news, tailored real-time data and analysis, business life and economic evaluations
A new global survey commissioned by Boehringer Ingelheim suggests that many pet owners still lack a clear understanding of parasite risks, even though infections are common and prevention options are widely available.
At Klivet in Turkiye, veterinary oncologist Sandra Gullien discussed how electrochemotherapy is gaining traction as a less invasive option for selected skin tumors in cats and dogs—especially when surgery would be difficult, disfiguring, or incomplete.
At the Klivet 16th Spring Congress in Turkiye, Prof. Ahmet Ozak described veterinary neurology as a field where time is the limiting factor. Unlike many orthopedic cases where surgery can be delayed, neurological patients require rapid decision-making, making a proper, structured neurologic exam essential.
At Klivet in Turkiye, veterinary oncologist Sandra Gullien discussed how electrochemotherapy is gaining traction as a less invasive option for selected skin tumors in cats and dogs—especially when surgery would be difficult, disfiguring, or incomplete.
Critical care specialist Dr. Andrew Linklater outlined three areas reshaping how veterinarians manage pancreatitis: better diagnostics, earlier nutrition, and emerging therapies.
Dr. Miguel Angel Diaz Sanchez addressed a persistent business reality in companion animal practice: veterinarians must charge for their work, yet many feel uncomfortable asking for payment. His message was clear—pricing becomes easier when it is introduced at the right moment in a well-structured consultation.
Cardiology speaker Laurent Locquet warned that one of the most frequent problems in small-animal cardiology is starting medication without a confirmed diagnosis—a practice that can lead to inappropriate treatment decisions in both dogs and cats.
The 7th International Veterinary Emergency and Critical Care Congress (TuVECCA) once again positioned itself as more than a scientific meeting, according to Congress President Doga Ozkul, who described this year’s edition as a “festival” shaped by both high-level education and a strong social message.
Levent Erdem, Pet Business Unit Director at Zoetis, described how the company’s long-term relationship with veterinarians has evolved into a trust-based partnership—driven by consistent product expansion and a strong feedback culture.
Purina PRO PLAN will hold its 2026 Calming Care Symposium under the theme “The Gut-Brain Axis in Practice”, with the goal of translating the science behind canine stress into practical learning for veterinary teams.
Diker said the brand’s motivation has long been centered on healthy and long living, positioning Longevity as a flagship product within the company’s super-premium pet food offering under the Reflex family.
Speaking from the congress venue, Can said Deva Holding and Vetas were present at the event and stressed that the company was “very pleased” with the opportunity to engage face-to-face with veterinarians.
Perissinotto stressed a time-critical message tied to updated guidance she referenced: do not waste time checking for a pulse in an unresponsive patient.
The UK government has opened a major consultation to overhaul the veterinary sector for the first time in six decades, aiming to make vet services clearer, fairer and more transparent for pet owners while supporting veterinary teams.
At the PRO PLAN Professionals Summit held on 22–23 October in Turkiye, Intrinsia Vet speakers Mike Clare and Dr. Liz Walker put veterinary clinic economics and operations at the center of the conversation, sharing practical frameworks on profitability, customer loyalty, and sustainable growth. The two-day event brought together veterinarians from multiple cities and blended scientific sessions with leadership and communication content.
Royal Canin has announced a key appointment as it continues to reinforce its organization in Turkiye. Burcu Terzioglu has joined the company as Veterinary and Professional Channel Sales and Marketing Director, bringing 16+ years of sales management and commercial leadership experience from the fast-moving consumer goods sector.
Royal Canin has announced the appointment of Asli Celikkol as General Manager for the Eurasia region, marking a new chapter of strategic regional leadership for the Mars Petcare company. The move follows her successful term as Country Manager for Royal Canin Turkiye, where she led a period of strong growth and organizational transformation.
During her more than five years in the Turkiye role, Celikkol guided the company through a major structural realignment, uniting sales, marketing, and operations teams under one coherent strategy. This integration helped strengthen Royal Canin’s market presence while enhancing agility in responding to the fast-changing pet care landscape. She also played a pivotal role in nurturing internal talent, enabling several Turkish professionals to move into global and regional leadership roles within the Mars and Royal Canin network.
Celikkol brings nearly 25 years of experience across diverse sectors. Before joining Mars Inc. in 2014, she worked with Henkel Turkiye, Vestel, and Aviva, where she gained solid experience in multi-channel sales, customer development, and strategic leadership. Within Mars and Royal Canin, she held several leadership positions focused on customer excellence and modern trade management, contributing significantly to the company’s strong reputation in Turkiye and beyond.
In her new role, Celikkol will oversee Royal Canin’s operations across the wider Eurasia region, aiming to strengthen partnerships with veterinary professionals, breeders, and distributors. Her appointment reflects Royal Canin’s ongoing investment in leadership diversity and its commitment to expanding the company’s reach in high-potential markets, where pet ownership and demand for tailored nutrition solutions are rapidly rising.
Royal Canin Turkiye has launched a pioneering Hologrammed QR Code Product Verification System to safeguard pet food authenticity, setting a new benchmark in the local pet nutrition market. The system, rolled out in July 2025, enables pet owners to instantly verify the originality of their purchased dry food packs by scanning the hologrammed QR code through the Royal Canin Up mobile app.
Committed to Excellence: Boehringer Ingelheim’s Continued Support for Veterinary Medicine in Turkiye
Przemek Zielinski, General Manager of Boehringer Ingelheim Animal Health Turkiye, attended the congress and shared his insights on the company’s role in supporting the veterinary community. “Boehringer Ingelheim is proud to be a strong partner for veterinarians,” he stated. “Since the beginning of my tenure in Turkiye, I have made it a point to attend many of the events organized within the veterinary sector. Klivet’s events stand out with their level of professionalism and their commitment to excellence — qualities that contribute significantly to the advancement of the veterinary profession in Turkiye.”
At the 2025 KLIVET Spring Congress in Istanbul, veterinary surgeon Dr. Mike Farrell, DipECVS, MRCVS, delivered a series of expert insights focused on one of the most pressing health issues in companion animals today: obesity and its orthopedic consequences. Speaking to a room of clinical veterinarians from across Turkiye and abroad, Farrell explored the growing clinical burden of obesity in cats and dogs, with a particular focus on its role in joint disease and mobility impairment.
At the KLIVET Spring Congress 2025 in Istanbul, renowned veterinary specialist Prof. Dr. Alexander James German from the University of Liverpool joined the scientific program as an invited speaker. Following his presentation, The Animal Economics had the opportunity to sit down with Prof. German to discuss a topic that’s becoming increasingly important in clinical nutrition: why senior cats require special dietary care.
MSD Animal Health, a division of Merck & Co., Inc. (NYSE:MRK), announced on June 12, 2025, that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion for its new NOBIVAC® L6 and LoVo L6 vaccines. If adopted by the European Commission later this year, these would become the first and only canine leptospirosis vaccines approved in the EU to offer broad protection—reducing or preventing mortality, clinical signs, infection, urinary excretion, and kidney damage caused by six Leptospira serovars.
One of the most thought-provoking speakers at KLIVET Spring Congress 2025 in Istanbul was Dr. Goran Cvetkovic, who addressed a topic that’s gaining urgent relevance across the veterinary world: the business side of clinical practice. As economic conditions continue to challenge veterinary professionals globally, Dr. Cvetkovic offered key insights into maintaining clinic profitability and avoiding common financial and managerial pitfalls.
The recent KLIVET Spring Congress offered more than just scientific discussion — it provided a rare, global lens into the future of veterinary medicine. For Ayla Ceren Tokgoz, a veterinary student and active member of the International Association of Veterinary Students – Turkiye (IAT), the congress held a particularly meaningful place.
“KLIVET is truly unique to me. It offers a rare opportunity to observe how veterinary medicine is approached in different countries, giving me a global perspective on the profession,” Tokgoz shared. This international dimension has become increasingly important as veterinary education and practice rapidly evolve worldwide.
The cost of veterinary care in the UK has become a flashpoint, pushing regulators to intervene.
Among the highlights of KLIVET was a presentation by Dr. Ashley Bourgeois, a renowned veterinary dermatologist from the United States. In her session, Dr. Bourgeois encouraged veterinary professionals to “think like a dermatologist” when approaching skin-related cases. She focused on the increasing prevalence of food-related allergies and allergic dermatitis, offering practical advice on diagnosis, case management, and client communication. Her insights were particularly relevant within the broader context of the congress theme, as she touched on how obesity can complicate dermatological conditions in companion animals.
Boehringer Ingelheim continues to lead in animal health innovation with the launch of Pexion, a groundbreaking treatment for canine idiopathic epilepsy, introduced at a scientific event in Istanbul on February 13th. Bringing together veterinary neurologists and clinicians, the event showcased Pexion, a novel therapy designed to manage epilepsy in dogs. Featuring expert insights from Prof. Dr. Holger Volk of the Royal Veterinary College and Dr. Philip Watson, Clinical Research Lead at Boehringer Ingelheim, the launch offered a deep dive into the latest developments in veterinary epilepsy care.
The active ingredient in Pexion, imepitoin, not only helps reduce seizure frequency but also improves quality of life through its anxiolytic properties. This dual benefit sets it apart from conventional antiepileptic treatments.
Opening the event, Orkun Bürün, Head of Boehringer Ingelheim Turkiye’s Pet Business Unit, emphasized the significance of this innovation: “With this launch, we are entering a new era in veterinary neurology. We’ve chosen to align this initiative with International Epilepsy Day in February to raise awareness about epilepsy in animals as well.”
Virbac Turkiye focused on the subject of parasitology in cats and dogs at its 360° parasite control meeting held in Istanbul. The meeting, attended by 280 Turkish veterinarians, had a congress-like atmosphere. Virbac Turkiye Manager Alican İngeç, who made the opening speech of the program, talked about the synergy arising from the combination of trust and quality. ’As you all know, we have been serving you, our valuable veterinarians, as Mopsan veterinary products in the sector for over 30 years.
The cutting-edge Purina® PRO PLAN® Symposium will bring together leading experts from across Europe to explore the latest integrative approaches to gastrointestinal health in companion animals. Held in collaboration with the EuroGut Society, the hybrid event will take place on 2nd April from 09.00 to 17.30 (CEST), 08:00 – 16:30 (BST) and is available to join free online.
Cutaneous adverse food reactions are a lifelong disorder, but when diagnosed correctly they can be easily managed through diet. The concept of elimination is relatively simple, but can be very challenging due to the cost of prescription foods and the length of time it takes to trial the diet. Food allergies, known as cutaneous adverse food reactions (CAFR), are immunologic reactions to food allergens. CAFR is thought to affect approximately 20 percent of dogs and 13 percent of cats with allergic skin disease. Proteins such as beef, chicken, dairy, soy, fish, and eggs are common allergens thought to trigger food allergies in dogs and cats.
Common symptoms
The most common symptoms associated with cutaneous adverse food reactions include: nonseasonal pruritus, usually on the face and neck, perianal pruritus, anal sacculitis, otitis externa, and recurrent secondary infections. In some cases, concurrent noncutaneous symptoms of a food allergy may include: gastrointestinal signs such as vomiting, diarrhea, bloating, conjunctivitis, respiratory signs, urticaria, seizures, and behavioral problems.
